Skip to main content

Time in Range

What's new

New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1 agonists as first-line injection therapy, and CGM metrics Continue Reading »

A low carb diet can be difficult to follow, especially for children. Katie Bacon explains several ways in which low carb principles can be adapted to real life Continue Reading »

As 2019 comes to an end, we reflect on a year of hope and growth, with immense gratitude for our community. In 2020 we will continue to focus on helping people with diabetes and prediabetes be their best selves Continue Reading »

FDA approves WellDoc’s BlueStar app (24/7 diabetes management coaching and support) for use in type 1 diabetes. BlueStar insights also now incorporate data from Dexcom CGM Continue Reading »

A new paper suggests that as people with diabetes increase their time in range, healthcare costs decrease Continue Reading »

Diabetes advocates, Renza and Grumpy, share the importance of #LanguageMatters and the consequences of  “grading” diabetes management Continue Reading »

What I've Learned From 70,000 Hours Wearing CGM - A Video Presentation at Thriveabetes 2019 Continue Reading »

What is it like having a sibling with diabetes, and what can someone do to support their sibling with diabetes? 20-year-old Alexandra Varon shares insight on having a younger sister with type 1 diabetes. Continue Reading »

Pages